❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ G. Mælandsmo's group ❭ Links ❭

Links

Search engines
  • Lycos
  • WhoWhere?
  • ABC startsiden
  • Allltheweb
  • Finn.no
  • Start.no
  • Twingine (Yagoohoogle)
  • Yahoo
  • Google
 Reference books
  • Telefonkatalogen
  • Britannica.com
  • Merriam-Webster
  • Wikipedia
  • Trafikanten

 

  • Forskernett Links
 Only from MR PCs or using VPN
  • IT info/status
  • Mittskrivebord
  • Personalportalen
  • Kompetanseutvikling
  • Telefonkatalogen
  • Servicedesk
  • EK Kvalitet
 Miscellaneous
  • The Norwegian Cancer Society
  • Universitetet i Oslo
  • The Norwegian Radium Hospital
  • Rikshospitalet
  • Helsenett
  • Forskningsrådet
  • Aftenposten
  • Dagbladet
  • VG
  • Virtual Oslo
  • NBS
  • Valutakalkulator
  • The ELSO
  • Meteorological Institute

 E-mail
  • Webmail UIO
  • Webmail Forskernett
     
  • Hotmail
  • Yahoo Mail
  • Gmail
Scroll to top

Home Dept. of Tumor Biology G. Mælandsmo's group

  • Group members
  • Research interests
  • Publications
  • Links

Recent publications

Valsala Kumari R, Pandya AD, Pettersen SJ, Kvalvaag A, Myrann AG, Ghiarasim R, Rotaru A, Dimofte MG, Skotland T, Sandvig K, Mari Mælandsmo G, Iversen TG (2025)
Evaluation of HER2 Targeted Poly(Ethylene Glycol)-Poly(L-histidine) Copolymer Micelles in Breast Cancer Models
Macromol Biosci, e00047 (in press)
DOI 10.1002/mabi.202500047, PubMed 40719176

Skourti E, Seip K, Mensali N, Jabeen S, Juell S, Øynebråten I, Pettersen S, Engebraaten O, Corthay A, Inderberg EM, Dolznig H, Mælandsmo GM, Egeland EV, Prasmickaite L (2025)
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer
Breast Cancer Res, 27 (1), 131
DOI 10.1186/s13058-025-02082-x, PubMed 40660361

Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, Seip K, Andressen KW, Linder A, Øijordsbakken M, Poutanen M, Katz B, Halvorsen B, Mælandsmo GM, Taskén KA (2025)
Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis
J Transl Med, 23 (1), 672
DOI 10.1186/s12967-025-06644-7, PubMed 40528241



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)